Diabetes medication(s)-Insulin Posts on Medivizor
Navigation Menu

Diabetes medication(s)-Insulin Posts on Medivizor

Comparing effectiveness and safety of combined insulin aspart 30 and metformin compared to insulin aspart 30 alone in patients with type 2 diabetes and different heart disease risk profiles

Comparing effectiveness and safety of combined insulin aspart 30 and metformin compared to insulin aspart 30 alone in patients with type 2 diabetes and different heart disease risk profiles

Posted by on May 16, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effectiveness and safety of biphasic insulin aspart 30 (BIAsp 30; NovoMix 30) alone or with metformin (Glucophage), in patients with inadequately controlled type 2 diabetes (T2D). The authors concluded that combined therapy may be preferred in patients with high cardiovascular risk and/or a body...

Read More

Comparing safety and effectiveness of liraglutide to insulin glargine after hospital discharge in patients with uncontrolled type 2 diabetes.

Comparing safety and effectiveness of liraglutide to insulin glargine after hospital discharge in patients with uncontrolled type 2 diabetes.

Posted by on Mar 28, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study compared the safety and effectiveness of liraglutide (Victoza) to insulin glargine (Lantus) on glycemic (blood glucose) control in patients with type 2 diabetes (T2D) after hospital discharge. The authors concluded that liraglutide treatment led to improved glycemic control and greater weight loss compared to...

Read More

Can hybrid closed-loop insulin delivery improve control of diabetes?

Can hybrid closed-loop insulin delivery improve control of diabetes?

Posted by on Dec 31, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study compared hybrid closed-loop (HCL) insulin delivery to an insulin pump or daily injections for adults with type 1 diabetes (T1D). It found that an HCL system led to better glucose control and a more positive experience of managing diabetes. Some background For many patients with T1D, managing blood glucose (sugar) levels is a...

Read More

Adding exenatide to insulin treatment in patients with type 2 diabetes

Adding exenatide to insulin treatment in patients with type 2 diabetes

Posted by on Nov 8, 2020 in Diabetes mellitus | 0 comments

In a nutshell This controlled trial looked at adding exenatide (Byetta) to intensive insulin treatment for patients with type 2 diabetes (T2D) who still had high blood sugar. It found that the exenatide improved blood sugar control and reduced body weight in these patients. Some background T2D is a metabolic condition in which the body does not...

Read More

Does insulin glargine-300 reduce the risk of hypoglycemia in patients with type 1 diabetes?

Does insulin glargine-300 reduce the risk of hypoglycemia in patients with type 1 diabetes?

Posted by on Jul 5, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study compared the risk of severe hypoglycemia (dangerously low blood glucose levels) with insulin glargine-100 (Lantus) and insulin glargine-300 (Toujeo) for patients with type 1 diabetes (T1D). It found that both medications improved glucose control, and insulin glargine-300 had a lower risk of hypoglycemia. Some background T1D is...

Read More

How safe and effective is non-insulin drug dapagliflozin long-term for patients with uncontrolled type 1 diabetes?

How safe and effective is non-insulin drug dapagliflozin long-term for patients with uncontrolled type 1 diabetes?

Posted by on May 17, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study compared two doses of dapagliflozin (Farxiga) to a placebo to determine how effective and safe they were long-term for patients with uncontrolled type 1 diabetes (T1D). The results showed that both doses were able to reduce blood glucose levels and body weight but increased the risk of ketoacidosis. Some background...

Read More

Can a non-insulin drug improve treatment results for patients with uncontrolled type 2 diabetes taking insulin?

Posted by on May 6, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study examined if non-insulin drug lixisenatide (Lyxumia) boosted treatment results from insulin glargine (Lantus) in patients with uncontrolled type 2 diabetes (T2D). Patients who received lixisenatide and glargine had improved blood glucose control and no significant increase in side effects. Some background Uncontrolled...

Read More

Looking for patients with diabetes receiving insulin to test mobile app

Posted by on Dec 20, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study is looking for patients with diabetes taking insulin to test a mobile app that helps patients understand how blood glucose levels change. The main outcome that will be measured is the average blood glucose level at the beginning versus the end of the study. This study is recruiting in Boston, MA, the US. The details...

Read More

Evaluating the Diabeloop insulin delivery system for patients with type 1 diabetes

Posted by on Nov 3, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study is comparing the effectiveness of two insulin delivery systems for patients with type 1 diabetes (T1D). The authors concluded that the Diabeloop system was more effective and better reduced high blood glucose levels in these patients. Some background Controlling blood glucose levels is an essential part of diabetes management....

Read More

How effective and safe is a closed-loop insulin pump for patients with type 1 diabetes?

Posted by on Oct 30, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effectiveness and safety of a closed-loop and sensor-augmented insulin pumps for patients with Type 1 diabetes (T1D). The authors found that the closed-loop device was more effective but had more side effects for these patients. Some background The main goal of treatment for T1D is to balance blood glucose...

Read More

Can ipragliflozin treatment help lower insulin dose in patients with T2D receiving insulin therapy?

Posted by on Oct 13, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the safety and effectiveness of ipragliflozin (Suglat) in patients with type 2 diabetes (T2D). This study concluded that ipragliflozin helped reduce insulin dose by 30%, with minimal side effects. Some background Treatment for T2D aims to achieve good blood glucose control while avoiding hypoglycemia (dangerously low...

Read More